Vinorelbine tartrate is a medication used in cancer treatment. It is an antineoplastic (anticancer) agent that belongs to the class of drugs known as vinca alkaloids. Vinorelbine is derived from the periwinkle plant (Catharanthus roseus).
The medication is commonly prescribed for the treatment of various cancers, including:
1. Non-small cell lung cancer (NSCLC): Vinorelbine is often used as a single agent or in combination with other chemotherapy drugs to treat advanced or metastatic NSCLC.
2. Breast cancer: It can be used as a treatment for advanced or metastatic breast cancer, either as a single agent or in combination with other medications.
3. Ovarian cancer: Vinorelbine may be used in the treatment of recurrent or refractory ovarian cancer.
4. Hodgkin's lymphoma: It has shown effectiveness in treating both newly diagnosed and relapsed or refractory Hodgkin's lymphoma.
5. Non-Hodgkin's lymphoma: Vinorelbine can be used in certain cases of non-Hodgkin's lymphoma, particularly when other treatments have not been successful.
Vinorelbine works by interfering with the microtubules in cancer cells, disrupting their normal function and preventing cell division, which ultimately leads to cell death. It is administered intravenously and is usually given in cycles with rest periods in between to allow the body to recover.
As with any medication, vinorelbine tartrate may cause side effects, which can vary from person to person. Some common side effects include nausea, vomiting, fatigue, hair loss, constipation, and lowered blood cell counts (which can increase the risk of infections or bleeding). Your doctor will monitor your condition closely during treatment and may adjust the dosage or provide supportive care to manage these side effects.
It's important to discuss any concerns or questions you may have about vinorelbine tartrate with your healthcare provider, as they can provide personalized information based on your medical history and the specific cancer being treated.